AGM
XENT

Alpine Global Management’s Intersect ENT, Inc XENT Stock Holding History

Alpine Global Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$2.8K – 708
2022
Q1 		$2.8K Buy
+100,000
New +$2.74M 0.63% 36

Alpine Global Management's XENT Position: Q2 2022 in Review

Alpine Global Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 100,000 shares — an estimated $2.8K sold.

Alpine Global Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $2.8K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Alpine Global Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Alpine Global Management sold 100,000 Intersect ENT, Inc shares in Q2 2022, an estimated $2.8K.
  • Alpine Global Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Alpine Global Management's Intersect ENT, Inc position peaked at $2.8K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Alpine Global Management's 13F filing for Q2 2022, filed 15 Aug 2022.